<DOC>
	<DOCNO>NCT00429910</DOCNO>
	<brief_summary>RATIONALE : Gathering information patient chronic myelogenous leukemia may help doctor learn disease find good method treatment on-going care . PURPOSE : This natural history study collect health information disease-related information time patient newly diagnose chronic myelogenous leukemia .</brief_summary>
	<brief_title>Natural History Study Patients With Chronic Myelogenous Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Determine impact current procedure diagnosis , management , follow-up disease status patient newly diagnose chronic myelogenous leukemia ( CML ) . - Determine natural history patient CML achieve response imatinib mesylate . - Determine health perception , symptom , insurance issue , work issue patient . - Determine whether medication compliance plan dose reduction affect imatinib mesylate effectiveness patient . - Determine molecular biologic factor associate disease progression good poor response imatinib mesylate patient . OUTLINE : This longitudinal , prospective , cohort study . Patients complete quality life , functional status , medical treatment history , medication questionnaire baseline every 6 month 5 year . Blood sample collect baseline every 6 month 5 year . Specimens may examine future gene array study mutation analysis .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<criteria>Age 18 year Diagnosis within one year enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>accelerated phase chronic myelogenous leukemia</keyword>
	<keyword>blastic phase chronic myelogenous leukemia</keyword>
	<keyword>chronic phase chronic myelogenous leukemia</keyword>
	<keyword>meningeal chronic myelogenous leukemia</keyword>
</DOC>